An American Patient’s Second Chance: An 18-Hour Liver Transplant in South Korea

 

Editorial illustration of a patient and caregiver, surgical team, liver anatomy and Seoul skyline for a story about an 18-hour living-donor liver transplant in South Korea.

How a Silicon Valley engineer with advanced liver disease received complex living-donor liver transplantation at Asan Medical Center in Seoul.

At a glance: Charles Carlson traveled from the United States to South Korea for a complex living-donor liver transplant in December 2018. His wife donated part of her liver. Following an 18-hour operation and prolonged recovery, he was discharged in February 2019.

When Treatment in the United States Became Complicated

In 2018, Charles Carlson, a software engineer from Silicon Valley, faced a serious medical crisis. He had liver cirrhosis and myelodysplastic syndrome (MDS), a disorder affecting the production of healthy blood cells. Although he had received care at Stanford Medical Center, his worsening liver condition made further treatment difficult. He was on a U.S. liver transplant waiting list, but the timing of a suitable deceased-donor organ was uncertain. According to Asan Medical Center's published account, he was advised to seek an evaluation at the center in Seoul, South Korea.

1. Why Was His Condition So Difficult to Treat?

Carlson had been diagnosed with cirrhosis and MDS in 2011. Cirrhosis progressively damages liver function, while MDS can cause anemia, infections and bleeding problems. Together, the conditions made major surgery especially challenging. A transplant might restore enough liver function to support further treatment, but it would also involve substantial risk. Living-donor liver transplantation became an option to evaluate. In this procedure, a medically suitable healthy donor gives part of their liver; both donor and recipient require careful assessment and follow-up.

2. Why Did He Travel to South Korea?

Carlson traveled to South Korea in November 2018 for evaluation at Asan Medical Center. Liver transplant surgeons worked with hematology specialists to assess his complex condition. The hospital reported reaching 5,000 cumulative living-donor liver transplants in 2018. His wife, Heidi Carlson, volunteered to donate part of her liver. Following evaluation, the team decided the operation could proceed. This was a highly individualized medical decision, not a routine or guaranteed treatment pathway for overseas patients.

3. December 19, 2018: An 18-Hour Operation

Carlson underwent living-donor liver transplantation on December 19, 2018. The operation was unusually difficult: he had extensive abdominal adhesions, portal vein thrombosis and abnormal collateral blood vessels. According to the hospital, the operation took approximately 18 hours and involved 16 packs of platelets and 20 packs of blood. The team also operated on his wife to obtain the donated liver portion. Surgeons and specialists had to coordinate closely throughout the complex procedure.

4. Nearly Two Months of Hospital Recovery

The operation was completed, but recovery was not immediate. The hospital reported that the transplanted liver recovered function more slowly than expected, while Carlson's bone marrow disorder complicated his postoperative care. By mid-February 2019, he had improved enough to transfer to a general ward. Staff celebrated his birthday on February 22. On February 25, 2019, he was discharged and returned to the United States, with plans to continue care at Stanford Medical Center. The publicly documented outcome is his recovery to hospital discharge. His current health status and long-term transplant outcomes are not established by the reports cited here.

5. What This Case Shows About Specialized Care

Carlson's case illustrates the value of experienced transplant teams, multidisciplinary planning and cooperation across countries. A hospital's surgical experience can matter when evaluating complex treatment options. But no single patient story proves that a procedure is appropriate for everyone, and transplant outcomes depend on the recipient, donor and many clinical factors. The most meaningful lesson is that a second specialist evaluation can sometimes reveal a treatment option worth considering.

6. Can International Patients Receive Liver Transplants in Korea?

International patients may ask Korean transplant centers to evaluate their medical records, but acceptance is not automatic. Living-donor transplantation requires a medically suitable donor, recipient eligibility, informed consent, ethical safeguards and compliance with applicable rules. Hospitals must evaluate the recipient and donor independently. Before arranging travel, families should ask whether records can be reviewed remotely, what donor assessment is needed, and how care will continue after returning home.

7. Questions to Ask Before Traveling

  • Medical eligibility: Can specialists review the diagnosis, liver function and other illnesses before travel?
  • Donor safety: Which tests and independent consent procedures are required for a potential donor?
  • Relevant experience: Has the center treated patients with similar risk factors?
  • Length of stay: What are the expected recovery periods for both recipient and donor?
  • Continuity of care: How will immunosuppressive medicines, lab tests and follow-up be coordinated with doctors back home?

8. A Second Chance Beyond Borders

Charles Carlson's story is an example of international cooperation in the treatment of a seriously ill patient. He received care in the United States, traveled to South Korea for a specialized operation and returned home with plans for continued treatment. It does not mean that every patient should travel abroad for transplantation. It does show why carefully chosen additional medical opinions may be valuable when treatment decisions are especially difficult. The goal is not simply to cross a border, but to find safe, appropriate care supported by a realistic long-term plan.

Sources and further reading

Verification scope: This account summarizes the patient's diagnosis, treatment and discharge as reported in 2019. Current health status and long-term outcomes are not established here.

Medical disclaimer: This article is for educational purposes only and is not medical advice. Transplant eligibility, donor suitability and risks require assessment by qualified medical professionals.

Editorial independence: Korea Medical Compass is an independent medical information publication. This is not a paid hospital promotion, and no referral commission is received.

Comments

Popular posts from this blog

A Daughter Flew from America to Save Her Mother: A Kidney Transplant in South Korea

U.S. vs. South Korea: How Much Do Common Surgeries Really Cost?

Cancer Care in Korea: How an American Patient Overcame an Insurance Delay